1. Home
  2. AVO vs MLYS Comparison

AVO vs MLYS Comparison

Compare AVO & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVO
  • MLYS
  • Stock Information
  • Founded
  • AVO 1983
  • MLYS 2019
  • Country
  • AVO United States
  • MLYS United States
  • Employees
  • AVO N/A
  • MLYS N/A
  • Industry
  • AVO Farming/Seeds/Milling
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVO Consumer Staples
  • MLYS Health Care
  • Exchange
  • AVO Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • AVO 850.0M
  • MLYS 893.0M
  • IPO Year
  • AVO 2020
  • MLYS 2023
  • Fundamental
  • Price
  • AVO $9.84
  • MLYS $16.67
  • Analyst Decision
  • AVO Strong Buy
  • MLYS Strong Buy
  • Analyst Count
  • AVO 2
  • MLYS 3
  • Target Price
  • AVO $15.50
  • MLYS $27.00
  • AVG Volume (30 Days)
  • AVO 422.3K
  • MLYS 1.9M
  • Earning Date
  • AVO 03-10-2025
  • MLYS 05-08-2025
  • Dividend Yield
  • AVO N/A
  • MLYS N/A
  • EPS Growth
  • AVO 612.38
  • MLYS N/A
  • EPS
  • AVO 0.57
  • MLYS N/A
  • Revenue
  • AVO $1,310,200,000.00
  • MLYS N/A
  • Revenue This Year
  • AVO N/A
  • MLYS N/A
  • Revenue Next Year
  • AVO N/A
  • MLYS N/A
  • P/E Ratio
  • AVO $17.24
  • MLYS N/A
  • Revenue Growth
  • AVO 31.14
  • MLYS N/A
  • 52 Week Low
  • AVO $9.54
  • MLYS $8.24
  • 52 Week High
  • AVO $15.25
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • AVO 28.20
  • MLYS 70.87
  • Support Level
  • AVO $9.71
  • MLYS $16.15
  • Resistance Level
  • AVO $10.28
  • MLYS $17.35
  • Average True Range (ATR)
  • AVO 0.41
  • MLYS 1.49
  • MACD
  • AVO -0.09
  • MLYS 0.39
  • Stochastic Oscillator
  • AVO 8.13
  • MLYS 80.37

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: